ICATIBANT
Generic: ICATIBANT
Hikma Pharmaceuticals USA Inc.Manufacturer
SUBCUTANEOUSRoute
ICATIBANT ACETATEActive Substance
2020-03-09Original Approval
ICATIBANT is FDA application ANDA211021, sponsored by JIANGSU HANSOH PHARM. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
HEREDITARY ANGIOEDEMA
1,025 reports
2
DRUG INEFFECTIVE
293 reports
3
WEIGHT INCREASED
277 reports
4
PRODUCT DOSE OMISSION ISSUE
267 reports
5
WEIGHT DECREASED
266 reports
6
PRODUCT USE ISSUE
251 reports
7
MALAISE
209 reports
8
HEADACHE
206 reports
9
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
191 reports
10
STRESS
181 reports